The Asia scoliosis management market size is projected to reach USD 826.8 million by 2027, exhibiting a CAGR of 6.1% during the forecast period. Consistent prevalence of spinal deformities in Asian populations will be the leading trend shaping the growth trajectory of this market, postulates Fortune Business Insights™ in its report. While no study has been conducted to identify the exact prevalence of scoliosis in Asia, several isolated researches have been undertaken to determine the incidence of the disease in different Asian countries. In Singapore, for example, prevalence of idiopathic scoliosis in 12- and 13-year-old female students was estimated to be 2.22% and 2.49%, respectively. In Taiwan, the incidence was 6.58% for a curve of 5 degrees and 2.4% for a curve of 10 degrees. A 2016 study conducted by the Ganga Hospital in Coimbatore, India found that 47% of the surveyed patients with congenital scoliosis suffered from intra-spinal anomalies, with tethered cord being the most common anomaly. Thus, the increasing prevalence of spinal deformities in Asia will stoke the adoption of scoliosis management technologies in the region in the coming years. Request a Sample Copy of the Research Report:  https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/asia-scoliosis-management-market-104534 Weakening Revenues amid COVID-19 to Hamper Market Growth The Asia scoliosis management market growth is likely to face a series of negative impacts as major medical devices companies have been suffering from unprecedented revenue shortfalls due to the coronavirus. In the early stages of the pandemic, Ireland-based Medtronic announced that its weekly sales plunged steeply as hospitals around the world put elective surgeries on hold. In March, for instance, the company’s sales in the US dipped by 60% while in China they fell by 40%. Similarly, Zimmer Biomet reported a massive decline of USD 1.78 billion in the first quarter of 2020 as 80% of the company’s revenues come from elective procedures. These companies are also confronting the sharp drop in non-essential surgeries worldwide. According to the University of Birmingham-led 120-country alliance called CovidSurg, nearly 28.4 million elective surgeries across the globe are likely to get canceled because of the coronavirus. The cumulative effect of these developments will inevitably hamper the companies’ investment plans in Asia, resulting in deflated market growth. Click here to get the short-term and long-term impact of COVID-19 on this market. Please visit: https://www.fortunebusinessinsights.com/asia-scoliosis-management-market-104534 About Us: Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in. Contact Us: Fortune Business Insights™ Pvt. Ltd U.S.: +1 424 253 0390 U.K.: +44 2071 939123 APAC: +91 744 740 1245Email:[email protected]